BACKGROUND: Abdominal aortic aneurysms (AAAs) in humans are associated with locally increased oxidative stress and activity of NADPH oxidase. We investigated the hypothesis that vitamin E, an antioxidant with documented efficacy in mice, can attenuate AAA formation during angiotensin II (Ang II) infusion in apolipoprotein E-deficient mice. METHODS AND RESULTS: Six-month-old male apolipoprotein E-deficient mice were infused with Ang II at 1000 ng/kg per minute for 4 weeks via osmotic minipumps while consuming either a regular diet or a diet enriched with vitamin E (2 IU/g of diet). After 4 weeks, abdominal aortic weight and maximal diameter were determined, and aortic tissues were sectioned and examined using biochemical and histological techniques. Vitamin E attenuated formation of AAA, decreasing maximal aortic diameter by 24% and abdominal aortic weight by 34% (P<0.05, respectively). Importantly, animals treated with vitamin E showed a 44% reduction in the combined end point of fatal+nonfatal aortic rupture (P<0.05). Vitamin E also decreased aortic 8-isoprostane content (a marker of oxidative stress) and reduced both aortic macrophage infiltration and osteopontin expression (P<0.05, respectively). Vitamin E treatment had no significant effect on the extent of aortic root atherosclerosis, activation of matrix metalloproteinases 2 or 9, serum lipid profile, or systolic blood pressure. CONCLUSIONS: Vitamin E ameliorates AAAs and reduces the combined end point of fatal+nonfatal aortic rupture in this animal model. These findings are consistent with the concept that oxidative stress plays a pivotal role in Ang II-driven AAA formation in hyperlipidemic mice.
BACKGROUND:Abdominal aortic aneurysms (AAAs) in humans are associated with locally increased oxidative stress and activity of NADPH oxidase. We investigated the hypothesis that vitamin E, an antioxidant with documented efficacy in mice, can attenuate AAA formation during angiotensin II (Ang II) infusion in apolipoprotein E-deficient mice. METHODS AND RESULTS: Six-month-old male apolipoprotein E-deficient mice were infused with Ang II at 1000 ng/kg per minute for 4 weeks via osmotic minipumps while consuming either a regular diet or a diet enriched with vitamin E (2 IU/g of diet). After 4 weeks, abdominal aortic weight and maximal diameter were determined, and aortic tissues were sectioned and examined using biochemical and histological techniques. Vitamin E attenuated formation of AAA, decreasing maximal aortic diameter by 24% and abdominal aortic weight by 34% (P<0.05, respectively). Importantly, animals treated with vitamin E showed a 44% reduction in the combined end point of fatal+nonfatal aortic rupture (P<0.05). Vitamin E also decreased aortic 8-isoprostane content (a marker of oxidative stress) and reduced both aortic macrophage infiltration and osteopontin expression (P<0.05, respectively). Vitamin E treatment had no significant effect on the extent of aortic root atherosclerosis, activation of matrix metalloproteinases 2 or 9, serum lipid profile, or systolic blood pressure. CONCLUSIONS:Vitamin E ameliorates AAAs and reduces the combined end point of fatal+nonfatal aortic rupture in this animal model. These findings are consistent with the concept that oxidative stress plays a pivotal role in Ang II-driven AAA formation in hyperlipidemic mice.
Authors: Takeshi K Nakahashi; Katsuyuki Hoshina; Philip S Tsao; Eiketsu Sho; Mien Sho; John K Karwowski; Cory Yeh; Ruey-Bing Yang; James N Topper; Ronald L Dalman Journal: Arterioscler Thromb Vasc Biol Date: 2002-12-01 Impact factor: 8.311
Authors: Gary G Deng; Baby Martin-McNulty; Drew A Sukovich; Ana Freay; Meredith Halks-Miller; Therese Thinnes; David J Loskutoff; Peter Carmeliet; William P Dole; Yi-Xin Wang Journal: Circ Res Date: 2003-02-13 Impact factor: 17.367
Authors: David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura Journal: J Vasc Surg Date: 2003-05 Impact factor: 4.268
Authors: Frank A Lederle; Gary R Johnson; Samuel E Wilson; David J Ballard; William D Jordan; John Blebea; Fred N Littooy; Julie A Freischlag; Dennis Bandyk; Joseph H Rapp; Atef A Salam Journal: JAMA Date: 2002-06-12 Impact factor: 56.272
Authors: Uchechukwu K Sampson; Prudhvidhar R Perati; Petra A Prins; Wellington Pham; Zhouwen Liu; Frank E Harrell; MacRae F Linton; John C Gore; Valentina Kon; Sergio Fazio Journal: J Ultrasound Med Date: 2011-06 Impact factor: 2.153
Authors: Uwe Raaz; Alexander M Zöllner; Isabel N Schellinger; Ryuji Toh; Futoshi Nakagami; Moritz Brandt; Fabian C Emrich; Yosuke Kayama; Suzanne Eken; Matti Adam; Lars Maegdefessel; Thomas Hertel; Alicia Deng; Ann Jagger; Michael Buerke; Ronald L Dalman; Joshua M Spin; Ellen Kuhl; Philip S Tsao Journal: Circulation Date: 2015-04-22 Impact factor: 29.690
Authors: Andrea L Sheehan; Samuel Carrell; Bryon Johnson; Bojana Stanic; Botond Banfi; Francis J Miller Journal: Atherosclerosis Date: 2011-02-24 Impact factor: 5.162
Authors: Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis Journal: Arterioscler Thromb Vasc Biol Date: 2008-05-01 Impact factor: 8.311